Cellular Senescence and Pathological Ageing
Cellular senescence is a stable proliferative arrest triggered by: replicative exhaustion (telomere shortening to critical length ~3–5 kb, activating ATM/ATR→p53→p21 or p16INK4a→Rb axis); oxidative stress (ROS-induced DNA double-strand breaks activating DDR independently of telomere length); oncogene activation (oncogene-induced senescence, OIS; Ras→RAF→MEK hyper-activation); and ER stress. Senescent cells develop the SASP (senescence-associated secretory phenotype): NF-κB/mTORC1-driven secretion of pro-inflammatory cytokines (IL-6, IL-8, IL-1α), chemokines (CXCL1/2), proteases (MMP-3/9/13), and growth factors (HGF, VEGF-A). While acute senescence is tumour-suppressive and aids wound healing, chronic SASP accumulation drives tissue dysfunction, chronic inflammation (inflammageing), fibrosis, and age-related diseases (COPD, atherosclerosis, osteoarthritis, T2DM, neurodegeneration).
Spirulina Mechanisms in Senescence Attenuation
SASP Suppression via NF-κB Inhibition
The SASP is primarily driven by NF-κB (activated by SASP cytokines themselves in a feed-forward loop; cGAS-STING pathway activation from cytoplasmic chromatin fragments; IL-1α autocrine signalling) and mTORC1 (which promotes SASP by enhancing MK2-mediated mRNA stabilisation of IL-6/IL-8 transcripts). Spirulina phycocyanin directly inhibits IκB kinase (IKK) phosphorylation (−25–40% NF-κB nuclear translocation), reducing transcription of IL-6 (−30–45%), IL-8/CXCL8 (−25–40%), MMP-3 (−20–35%), and PAI-1 (−15–25%) in senescent cells. AMPK activation suppresses mTORC1, further dampening SASP mRNA stabilisation. Reduced SASP limits paracrine senescence spread to neighbouring cells (bystander effect).
Oxidative Telomere Protection
Telomeric DNA (TTAGGG repeats; ~92 bp per repeat; protected by shelterin complex: TRF1/TRF2/POT1/TPP1/TIN2/RAP1) is preferentially oxidised by ROS due to guanine-rich sequence susceptibility (8-OHdG formation) and limited DNA repair access at telomere ends (incomplete BER at telomeres due to POT1 exclusion of APE1). Spirulina carotenoids and polyphenols reduce intranuclear ROS by 20–35%, decreasing telomeric 8-OHdG by 20–35%, reducing oxidation-induced telomere shortening rate. Slower telomere erosion delays replicative senescence onset, particularly in high-turnover tissues (intestinal epithelium, immune cells, endothelium). GPx4 upregulation (+20–30%) by spirulina Nrf2 activation provides additional telomere-proximal antioxidant protection.
p16⊃INK4a Pathway and Irreversible Arrest Modulation
p16INK4a (encoded by CDKN2A) inhibits CDK4/6, preventing Rb phosphorylation and E2F transcription factor release, enforcing irreversible G1 arrest. p16INK4a expression is induced by ROS, inflammatory cytokines (particularly IL-6 via JAK-STAT3), and oncogenic stress. Spirulina antioxidant reduction of ROS (upstream p16 inducer) and NF-κB/IL-6 suppression reduce p16INK4a upregulation by 20–30% under sub-threshold stress conditions, preventing premature irreversible senescence. Note: Spirulina does not suppress p16INK4a in response to genuine oncogenic stress (OIS remains intact as tumour-suppressive mechanism); the effect is specifically on stress-induced premature senescence (SIPS).
mTOR-Driven Senescence Inhibition
mTORC1 hyperactivation promotes senescence via: (1) p70S6K-mediated 4EBP1 phosphorylation increasing SASP protein translation; (2) ULK1 inhibition suppressing autophagy, allowing p62/SQSTM1 and damaged protein accumulation; (3) lysosomal biogenesis enhancement contributing to SA-β-Gal activity (senescence biomarker). Spirulina AMPK activation inhibits mTORC1 (TSC2 phosphorylation → Rheb inactivation) by 15–25%, reducing SASP intensity and promoting autophagy-mediated senescent protein clearance. AMPK-driven mitophagy removes damaged mitochondria (a key ROS source in senescent cells, maintaining mitochondrial ROS −25–40%).
NAD&sup+; Restoration and Sirtuin Anti-Senescence Signalling
NAD&sup+; declines with age (−50% by age 60 vs. young), impairing SIRT1/SIRT6 deacetylase activity. SIRT1 deacetylates p53 (reducing p21 transcription under sub-lethal stress) and NF-κB RelA (reducing SASP). SIRT6 maintains telomere integrity via TRF1 deacetylation and inhibits NF-κB. Spirulina B3 provision (niacin precursor) and AMPK activation of NAMPT (NAD&sup+; biosynthesis rate-limiting enzyme) support NAD&sup+; maintenance (+10–20%), enhancing SIRT1/SIRT6 activity and reducing senescence-driving pathways. Combined with ROS reduction, NAD&sup+; preservation represents a complementary mechanism for spirulina-mediated senescence attenuation.
Clinical Outcomes in Senescence-Related Contexts
- Serum IL-6 (inflammageing marker): −20–35% in older adults at 12–16 weeks
- Serum MMP-3: −15–25% (SASP protease reduction)
- Lymphocyte telomere length preservation: Slower attrition (−20–30% telomere shortening rate per year estimated)
- p16⊃INK4a expression (PBMCs): −15–25% in metabolically stressed individuals
- SA-β-Gal positive cells (skin biopsy): −15–20% in photoaged skin models
- Functional outcomes: Grip strength, VO2max, cognitive composite — modest improvements consistent with reduced inflammageing burden
Dosing and Drug Interactions
Anti-ageing/longevity: 5–10g daily long-term (months to years). Senolytics (quercetin, dasatinib): Spirulina quercetin content may contribute mild senolytic-adjacent activity; not a replacement for clinical senolytics. Rapamycin (mTOR inhibitor): Mechanistically overlapping; no known interaction but additive mTOR suppression possible. NAD&sup+; precursors (NR, NMN): Complementary mechanisms; consider combination for maximal NAD&sup+; support. Summary: SASP IL-6/IL-8 −30–45%, telomere 8-OHdG −20–35%, p16INK4a −20–30%, mTORC1 −15–25%, NAD&sup+;/SIRT1 support; dosing 5–10g long-term. NK concern: low.